4//SEC Filing
Linde Peter 4
Accession 0001209191-21-037927
CIK 0001679363other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 7:15 PM ET
Size
7.4 KB
Accession
0001209191-21-037927
Insider Transaction Report
Form 4
Linde Peter
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-06-01$49.72/sh−4,648$231,100→ 5,952 total - Sale
Common Stock
2021-06-01$50.30/sh−1,352$68,010→ 4,600 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.06 to $50.05 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.06 to $50.87 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Morphic Holding, Inc.
CIK 0001679363
Entity typeother
Related Parties
1- filerCIK 0001805908
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 7:15 PM ET
- Size
- 7.4 KB